[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@JamesEKrause Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1091405261741404162.png) @JamesEKrause Biotech Jim

Biotech Jim posts on X about $crvs, $nvo, $omer, novo the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1091405261741404162/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:interactions.svg)

- X Week XXXXXX +67%
- X Month XXXXXX +160%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +56%

### Mentions: X [#](/creator/twitter::1091405261741404162/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:posts_active.svg)

- X Months XX -XX%
- X Year XXX +185%

### Followers: XXXXXX [#](/creator/twitter::1091405261741404162/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:followers.svg)

- X Week XXXXXX +0.19%
- X Month XXXXXX +1.60%
- X Months XXXXXX +9.10%
- X Year XXXXXX +18%

### CreatorRank: XXXXXXX [#](/creator/twitter::1091405261741404162/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1091405261741404162/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1091405261741404162/influence)
---

**Social category influence**
[stocks](/list/stocks)  X% [finance](/list/finance)  X%

**Social topic influence**
[$crvs](/topic/$crvs) #3, [$nvo](/topic/$nvo) #187, [$omer](/topic/$omer) 1%, [novo](/topic/novo) 1%, [all the](/topic/all-the) 1%, [nvo](/topic/nvo) 1%, [$idya](/topic/$idya) 1%, [$23b](/topic/$23b) 1%, [free to](/topic/free-to) 1%, [$akro](/topic/$akro) X%

**Top accounts mentioned or mentioned by**
[@semodough](/creator/undefined) [@c16h14n2oaqua](/creator/undefined) [@taeyoon43334145](/creator/undefined) [@biopharmiq](/creator/undefined) [@persimmonti](/creator/undefined) [@pjamess69](/creator/undefined) [@viewfromahill9](/creator/undefined) [@omillionaires](/creator/undefined) [@johnpdalyjr](/creator/undefined) [@wallstsai](/creator/undefined) [@tejada444](/creator/undefined) [@mathlonning](/creator/undefined) [@playertwoq](/creator/undefined) [@seedy19tron](/creator/undefined) [@naturemedicine](/creator/undefined) [@sentivcapital](/creator/undefined) [@1ccocccc1c1ccc2nccc2c1con1ccc2nncc2c](/creator/undefined) [@h1cn1ccnc2ccc3ncncc3c2fc1oc1ccccfccc1c](/creator/undefined) [@1cc](/creator/undefined) [@h1cc1noconh1hc](/creator/undefined)

**Top assets mentioned**
[Novo-Nordisk (NVO)](/topic/$nvo) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Akropolis (AKRO)](/topic/$akro) [Axcelis Technologies Inc (ACLS)](/topic/$acls)
### Top Social Posts [#](/creator/twitter::1091405261741404162/posts)
---
Top posts by engagements in the last XX hours

"On Omeros the promise may ultimately be reached via the asset purchase by $NVO of their MASP-3 inhibitor OMS-906. $OMER tired me out many moons ago. After all the main point of Waiting for Godot was to explore the absurdity and meaninglessness of existence"  
[X Link](https://x.com/JamesEKrause/status/1978466741383561333) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-15T14:23Z 13.2K followers, 2809 engagements


"$NVO Novo Nordisk to Acquire Akero Therapeutics for Up to $XXX Billion"  
[X Link](https://x.com/JamesEKrause/status/1976252303830380791) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-09T11:44Z 13.2K followers, 2011 engagements


"Performing some DD on $IDYA IDEAYA Biosciences trying to get a synopsis of their many biopharma collaborations. New to this name fwiw. Some friends of mine on X believe this company may be a buyout candidate. Current mkt cap $2.3B with some uncertainty of # of fully diluted shares (stock option grants etc). As usual please feel free to provide commentary (+ and -) on this interesting company/business plan. Partnered Programs and Collaborative Details via Grok my consultant. IDEAYA Biosciences has established multiple strategic partnerships to advance its precision oncology pipeline focusing"  
[X Link](https://x.com/JamesEKrause/status/1977085929811583266) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-11T18:56Z 13.2K followers, 16.5K engagements


"$AKRO Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to MASHby Both Completer and ITT Analysesat Week XX in Phase 2b SYMMETRY Study January XX 2025"  
[X Link](https://x.com/JamesEKrause/status/1883842446616146231) [@JamesEKrause](/creator/x/JamesEKrause) 2025-01-27T11:40Z 13.2K followers, 7089 engagements


"Regarding the accurate spelling of Aclaris $ACLS. Disclosure: I picked up some share ystdy for the 2026 ews flow. Never really followed the company before as they are friends with the 'bad luck bears'. Their approaches today are reasonable but 2026 is do or die. Activist investors such as Kevin T may have helped buoy the ship but it is all about the next yr company trial readouts. For the #ITK inhibitor with more acute selectivity (IND in 2026) this may be too little too late if the clintrials do not pan out. I invested since I like the risk reward but I sure would like to know the FDA regs"  
[X Link](https://x.com/JamesEKrause/status/1978577493327331655) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-15T21:43Z 13.2K followers, 1333 engagements


"The Brewers in the Brewers-Dodgers game last evening had this quite impressive yet bizarre double play"  
[X Link](https://x.com/JamesEKrause/status/1978138500529537305) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-14T16:39Z 13.2K followers, 1379 engagements


"A $CRVS ITK degrader program would definitely be of interest. I would assume significant ongoing competition"  
[X Link](https://x.com/JamesEKrause/status/1970833458353304044) [@JamesEKrause](/creator/x/JamesEKrause) 2025-09-24T12:51Z 13.2K followers, 4281 engagements


"$CRVS is starting to get recognized"  
[X Link](https://x.com/JamesEKrause/status/1978536636733391182) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-15T19:01Z 13.2K followers, 9945 engagements


"On the ITK enzyme and its inhibition for TH2 inflammatory diseases. I will be listening in on the Aclarus presentations today: Aclaris Therapeutics to Host In-Person and Webcast R&D Day Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets in New York on October XX 2025 $ACRS $CRVS"  
[X Link](https://x.com/JamesEKrause/status/1978082130614698409) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-14T12:55Z 13.2K followers, 8671 engagements


"On the heterogeneity of Metabolic Dysfunction-Associated Steatotic Liver Disease"  
[X Link](https://x.com/JamesEKrause/status/1976646954235875617) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-10T13:52Z 13.2K followers, 2366 engagements